7/15/2020, 12:27 PM (Source: TeleTrader)
more TeleTrader news

Oxford COVID-19 vaccine showing progress - report

Oxford COVID-19 vaccine candidate developed by British biopharma company AstraZeneca has shown progress in the initial trials, ITV reported on Wednesday.

According to sources, "there is a growing body of evidence suggesting the T-cells response is important in the defense against the novel coronavirus." Oxford's vaccine seems to be generating antibody and T-cell (killer cell) response the researchers hoped to see, according to the report.

AstraZeneca's progress on the vaccine is now in the third and last phase of the testing. If it proves to be safe and effective, mass production could start in September.

Breaking the News / ND